Cargando…
Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature
(1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies. Cerebral vein thrombosis (CVT) is a rare form of cerebrovascular accident and an uncommon AP...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699363/ https://www.ncbi.nlm.nih.gov/pubmed/34942943 http://dx.doi.org/10.3390/brainsci11121641 |
_version_ | 1784620496653910016 |
---|---|
author | Jerez-Lienas, Alba Mathian, Alexis Aboab, Jenifer Crassard, Isabelle Hie, Miguel Cohen-Aubart, Fleur Haroche, Julien Wahl, Denis Cervera, Ricard Amoura, Zahir |
author_facet | Jerez-Lienas, Alba Mathian, Alexis Aboab, Jenifer Crassard, Isabelle Hie, Miguel Cohen-Aubart, Fleur Haroche, Julien Wahl, Denis Cervera, Ricard Amoura, Zahir |
author_sort | Jerez-Lienas, Alba |
collection | PubMed |
description | (1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies. Cerebral vein thrombosis (CVT) is a rare form of cerebrovascular accident and an uncommon APS manifestation; the information in the literature about this feature consists of case reports and small case series. Our purpose is to describe the particular characteristics of CVT when occurs as part of the APS and compare our series with the patients published in the literature. (2) Methods: We conducted a retrospective observational study collecting data from medical records in three referral centers for APS and CVT, and a systematic review of the literature for CVT cases in APS patients. (3) Results: Twenty-seven APS patients with CVT were identified in our medical records, the majority of them diagnosed as primary APS and with the CVT being the first manifestation of the disease; additional risk factors for thrombosis were identified. The review of the literature yielded 86 cases, with similar characteristics as those of our retrospective series. (4) Conclusions: To our knowledge, our study is the largest CVT series in APS patients published to date, providing a unique point of view in this rare thrombotic manifestation. |
format | Online Article Text |
id | pubmed-8699363 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86993632021-12-24 Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature Jerez-Lienas, Alba Mathian, Alexis Aboab, Jenifer Crassard, Isabelle Hie, Miguel Cohen-Aubart, Fleur Haroche, Julien Wahl, Denis Cervera, Ricard Amoura, Zahir Brain Sci Article (1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies. Cerebral vein thrombosis (CVT) is a rare form of cerebrovascular accident and an uncommon APS manifestation; the information in the literature about this feature consists of case reports and small case series. Our purpose is to describe the particular characteristics of CVT when occurs as part of the APS and compare our series with the patients published in the literature. (2) Methods: We conducted a retrospective observational study collecting data from medical records in three referral centers for APS and CVT, and a systematic review of the literature for CVT cases in APS patients. (3) Results: Twenty-seven APS patients with CVT were identified in our medical records, the majority of them diagnosed as primary APS and with the CVT being the first manifestation of the disease; additional risk factors for thrombosis were identified. The review of the literature yielded 86 cases, with similar characteristics as those of our retrospective series. (4) Conclusions: To our knowledge, our study is the largest CVT series in APS patients published to date, providing a unique point of view in this rare thrombotic manifestation. MDPI 2021-12-13 /pmc/articles/PMC8699363/ /pubmed/34942943 http://dx.doi.org/10.3390/brainsci11121641 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jerez-Lienas, Alba Mathian, Alexis Aboab, Jenifer Crassard, Isabelle Hie, Miguel Cohen-Aubart, Fleur Haroche, Julien Wahl, Denis Cervera, Ricard Amoura, Zahir Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature |
title | Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature |
title_full | Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature |
title_fullStr | Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature |
title_full_unstemmed | Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature |
title_short | Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature |
title_sort | cerebral vein thrombosis in the antiphospholipid syndrome: analysis of a series of 27 patients and review of the literature |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699363/ https://www.ncbi.nlm.nih.gov/pubmed/34942943 http://dx.doi.org/10.3390/brainsci11121641 |
work_keys_str_mv | AT jerezlienasalba cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature AT mathianalexis cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature AT aboabjenifer cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature AT crassardisabelle cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature AT hiemiguel cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature AT cohenaubartfleur cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature AT harochejulien cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature AT wahldenis cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature AT cerveraricard cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature AT amourazahir cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature |